2019
DOI: 10.1016/j.biopha.2019.01.049
|View full text |Cite
|
Sign up to set email alerts
|

Acetylshikonin stimulates glucose uptake in L6 myotubes via a PLC-β3/PKCδ-dependent pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 34 publications
0
6
0
Order By: Relevance
“…Similar to the above, various A/S derivatives have exhibited anti-obesity and anti-diabetic activities, such as a commercial sample of ACS ( Huang et al, 2019 ) isolated from Lithospermum erythrorhizon Siebold and Zucc. root extracts ( Gwon et al, 2012 ; Su M. L. et al, 2016 ; Su M et al, 2016 ), DMAS from Arnebia euchroma (Royle) I. M. Johnst.…”
Section: Introductionmentioning
confidence: 78%
“…Similar to the above, various A/S derivatives have exhibited anti-obesity and anti-diabetic activities, such as a commercial sample of ACS ( Huang et al, 2019 ) isolated from Lithospermum erythrorhizon Siebold and Zucc. root extracts ( Gwon et al, 2012 ; Su M. L. et al, 2016 ; Su M et al, 2016 ), DMAS from Arnebia euchroma (Royle) I. M. Johnst.…”
Section: Introductionmentioning
confidence: 78%
“…However, the contraction-induced release of reactive oxygen species (ROS) and activation of AMP activated protein kinase (AMPK) may also lead to increased glucose uptake in skeletal muscle cells ( Mao, Yu, Li, & Li, 2008 , Su et al, 2016 ). Subsequently, acetylshikonin-induced glucose uptake was significantly inhibited by reduction of PLC-β3 in L6 myotubes, which makes it evident that acetylshikonin-induced glucose uptake may be triggered by activation of inositol lipid signaling and increased DAG release ( Huang et al, 2019 ). On the other hand, ageing is also considered as biggest cause of Alzheimer’s disease.…”
Section: Pharmacological Activitiesmentioning
confidence: 99%
“…Acetylshikonin treatment could ameliorate diabetic nephropathy (DN) in mice through attenuation of renal inflammation, decrease in kidney fibrosis, and inhibition of the activation of TGF-b1/Smad pathway . In another study, acetylshikonin enhanced glucose transporter 4 translocation and induced glucose uptake in L6 myotubes via the PLC-b3/PKCd pathway to reduce blood glucose (Huang et al 2019). Free fatty acid receptor (FFA) 4 is a member of the G-protein coupled receptors, which may play a role in diabetes treatment and other diseases (Milligan et al 2017).…”
Section: Antidiabetic Effect Of Acetylshikoninmentioning
confidence: 99%
“…In another study, acetylshikonin enhanced glucose transporter 4 translocation and induced glucose uptake in L6 myotubes via the PLC-β3/PKCδ pathway to reduce blood glucose (Huang et al. 2019 ). Free fatty acid receptor (FFA) 4 is a member of the G-protein coupled receptors, which may play a role in diabetes treatment and other diseases (Milligan et al.…”
Section: Pharmacologymentioning
confidence: 99%
See 1 more Smart Citation